This inventor holds 2 USPTO granted patents. Top assignee: Adaptive Biotechnologies Corporation. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Joyce K. Hu: Innovator in T Cell Receptor Technology
Introduction
Joyce K. Hu is a prominent inventor based in Seattle, WA, known for her significant contributions to the field of immunology. She has developed innovative methods for determining antigen-specific T cells, particularly focusing on the Wilms' tumor antigen-1 (WT1) protein. Her work has implications for cancer research and therapeutic applications.
Latest Patents
Joyce K. Hu holds a patent for "Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)." This invention is directed to methods for determining antigen-specific T cells and T cell receptors that bind specifically to an epitope of the WT1 protein. The patent also includes polynucleotides encoding the TCRs, engineered cells expressing the TCRs, and methods for making and using these TCRs and/or cells.
Career Highlights
Joyce is associated with Adaptive Biotechnologies Corporation, where she continues to advance her research in T cell receptor technology. Her work is pivotal in developing new strategies for cancer immunotherapy.
Collaborations
Joyce has collaborated with notable colleagues, including Timothy Lee Hayes and Edward J. Osborne, contributing to the advancement of their shared research goals.
Conclusion
Joyce K. Hu's innovative work in T cell receptor technology exemplifies her commitment to advancing cancer research. Her contributions are vital for the development of targeted immunotherapies, showcasing the importance of her inventions in the medical field.